BIOMAT Database Logo BIOMAT Database Logo

Synthesis of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines as antimicrobial agents with potential inhibition of DHPS enzyme. 2018

Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.

The development of a new class of antimicrobial agents is the optimal lifeline to scrap the escalating jeopardy of drug resistance. This study aims to design and synthesize a series of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines, to develop agents having antimicrobial activity through potential inhibition of dihyropteroate synthase enzyme. The target compounds have been evaluated for their in-vitro antimicrobial activity. Compounds 5b, 5c were equipotent (minimal inhibitory concentration = 12.5 μg/ml) to ampicillin. The docking patterns of 5b and 5c demonstrated that both fit into Bacillus Anthracis dihydropteroate synthase pterin and p-amino benzoic acid-binding pockets. Moreover, their physicochemical properties and pharmacokinetic profiles recommend that they can be considered drug-like candidates. The results highlight some significant information for the future design of lead compounds as antimicrobial agents.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004094 Dihydropteroate Synthase An enzyme that catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. EC 2.5.1.15. Dihydropteroate Pyrophosphorylase,Dihydropteroate Synthetase,Pyrophosphorylase, Dihydropteroate,Synthase, Dihydropteroate,Synthetase, Dihydropteroate
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001408 Bacillus anthracis A species of bacteria that causes ANTHRAX in humans and animals.
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
August 1997, Die Pharmazie,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines.
November 1999, Die Pharmazie,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis of pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-ones as potential antimicrobial agents.
May 2013, Archives of pharmacal research,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-Triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity.
December 1997, Archiv der Pharmazie,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
October 2006, Archiv der Pharmazie,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
September 2019, Bioorganic chemistry,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis and electrophilic substitutions of novel pyrazolo[1,5-c]-1,2,4-triazolo[4,3-a]pyrimidines.
August 2011, Molecules (Basel, Switzerland),
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
March 1985, Journal of medicinal chemistry,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents.
May 2017, Archiv der Pharmazie,
Maryam A Z El-Attar, and Rasha Y Elbayaa, and Omaima G Shaaban, and Nargues S Habib, and Abeer E Abdel Wahab, and Ibrahim A Abdelwahab, and Soad A M El-Hawash
Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents.
January 2011, Acta poloniae pharmaceutica,
Copied contents to your clipboard!